Under construction – not a live service
Sign in
Not yet taking people in UgandaNo phase

Health Education Study for Teens Living With Epilepsy

Tests a health education session on knowledge, medicine use and stigma in teens with epilepsy.

Plain-language title generated from the registry record
Registry title: Health Literacy Project

Key facts

Where
Mbarara, UgandaSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 12 and 18 years old?

Source: NCT06634901, who can take part

Where in Uganda

  • Mayanja Memorial HospitalMbarara, UgandaNo longer taking part
  • Mbarara Regional Referral HospitalMbarara, UgandaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Duke University
Trial code
NCT06634901
Record updated
9 September 2026
Original description
Evaluating changes in knowledge, attitude, and practices (KAP) related to epilepsy and its treatment as a result of an educational intervention among adolescents with epilepsy to determine if improved KAP about epilepsy results in improved medication adherence and less perceived stigma.Read full original descriptionShow less

The Impact of Health Literacy Education on Knowledge, Treatment Adherence and Stigma Among Adolescents With Epilepsy

Evaluating changes in knowledge, attitude, and practices (KAP) related to epilepsy and its treatment as a result of an educational intervention among adolescents with epilepsy to determine if improved KAP about epilepsy results in improved medication adherence and less perceived stigma.

Inclusion: Adolescents with a diagnosis of epilepsy attending a clinic at one of the study sites; Ages 12-18 years; Ability and willingness to provide informed assent and guardian consent to participate in the study; English, Runyankole or Luganda language proficiency.

Exclusion: Unable or unwilling to provide informed consent or assent to participate in the study; Developmental/cognitive challenges that hinder participation in the intervention or completion of surveys.

ClinicalTrials.gov NCT06634901